Aprea Therapeutics AB
Records under this name other than the patents Aprea Therapeutics AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 4 of 4 · Back to Aprea Therapeutics AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,759,361 | Azabicyclooctan-3-one derivatives and use thereof Term ended Term ended Jun 2, 2025 · USPTO record | Term ended | Term ended Jun 2, 2025 | USPTO record |
| US 7,659,278 | Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases Term ended Term ended May 18, 2024 · USPTO record | Term ended | Term ended May 18, 2024 | USPTO record |
| US 7,348,330 | 1-azabicyclo [2,2,2] octan-3-one derivatives Term ended Term ended Mar 31, 2022 · USPTO record | Term ended | Term ended Mar 31, 2022 | USPTO record |
| US 6,921,765 | 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors Term ended Term ended Dec 30, 2021 · USPTO record | Term ended | Term ended Dec 30, 2021 | USPTO record |